Twist Bioscience Corp. (TWST)
140.74
-4.85
(-3.33%)
USD |
NASDAQ |
Aug 24, 16:00
138.00
-2.74
(-1.95%)
After-Hours: 20:00
Twist Bioscience Shareholders Equity (Quarterly) : 445.74M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 445.74M |
| March 31, 2026 | 455.09M |
| December 31, 2025 | 456.10M |
| September 30, 2025 | 472.96M |
| June 30, 2025 | 478.20M |
| March 31, 2025 | 440.11M |
| December 31, 2024 | 455.94M |
| September 30, 2024 | 472.69M |
| June 30, 2024 | 491.14M |
| March 31, 2024 | 560.13M |
| December 31, 2023 | 590.04M |
| September 30, 2023 | 623.43M |
| June 30, 2023 | 657.55M |
| March 31, 2023 | 703.93M |
| December 31, 2022 | 746.32M |
| September 30, 2022 | 789.38M |
| June 30, 2022 | 820.68M |
| March 31, 2022 | 863.36M |
| Date | Value |
|---|---|
| December 31, 2021 | 626.18M |
| September 30, 2021 | 580.82M |
| June 30, 2021 | 610.45M |
| March 31, 2021 | 614.18M |
| December 31, 2020 | 637.95M |
| September 30, 2020 | 336.26M |
| June 30, 2020 | 348.95M |
| March 31, 2020 | 264.20M |
| December 31, 2019 | 103.08M |
| September 30, 2019 | 152.08M |
| June 30, 2019 | 176.00M |
| March 31, 2019 | 115.48M |
| December 31, 2018 | 138.60M |
| September 30, 2018 | 89.06M |
| June 30, 2018 | 95.75M |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | 66.28M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | 1.067B |
| Prime Medicine, Inc. | 39.81M |
| Intellia Therapeutics, Inc. | 727.71M |
| 10X Genomics, Inc. | 825.55M |
| Generate Biomedicines, Inc. | 456.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 672.44M |
| Total Liabilities (Quarterly) | 226.70M |
| Debt to Equity Ratio | 0.21 |
| Current Ratio | 2.672 |
| Net Debt Paydown Yield | -0.04% |